{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:57:11Z","timestamp":1781459831971,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002842","name":"Chiang Mai University","doi-asserted-by":"publisher","award":["R000030090"],"award-info":[{"award-number":["R000030090"]}],"id":[{"id":"10.13039\/501100002842","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012544","name":"China Medical University, Taiwan","doi-asserted-by":"publisher","award":["1230\/2567"],"award-info":[{"award-number":["1230\/2567"]}],"id":[{"id":"10.13039\/501100012544","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.imbio.2025.153134","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:48:24Z","timestamp":1761788904000},"page":"153134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of neutralizing anti-IFN-\u03b3 autoantibodies on GBP5 expression and monocyte dysfunction in adult-onset immunodeficiency"],"prefix":"10.1016","volume":"230","author":[{"given":"Kanokporn","family":"Sornsuwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"On-anong","family":"Juntit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanyarat","family":"Thongheang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkarat","family":"Wongsawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatchai","family":"Tayapiwatana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umpa","family":"Yasamut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2025.153134_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215581","article-title":"Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-gamma autoantibodies","volume":"14","author":"Angkasekwinai","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imbio.2025.153134_bb0010","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/cid\/cix996","article-title":"Clinical significance of interferon-\u03b3 neutralizing autoantibodies against disseminated nontuberculous mycobacterial disease","volume":"66","author":"Aoki","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.imbio.2025.153134_bb0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cytogfr.2009.02.004","article-title":"Interferon-gamma: a historical perspective","volume":"20","author":"Billiau","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.imbio.2025.153134_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.59","article-title":"Guanylate-binding protein 5 is a marker of interferon-gamma-induced classically activated macrophages","volume":"5","author":"Fujiwara","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.imbio.2025.153134_bb0025","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1186\/s12903-024-05295-2","article-title":"Guanylate-binding protein 5-mediated autophagy can promote the clearance of intracellular F. nucleatum in dental pulp cells during pulpitis","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.imbio.2025.153134_bb0030","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1038\/s41598-019-41952-1","article-title":"Functional neutralization of anti-IFN-gamma autoantibody in patients with nontuberculous mycobacteria infection","volume":"9","author":"Krisnawati","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imbio.2025.153134_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1629258","article-title":"Blockade effects of anti-interferon-(IFN-) gamma autoantibodies on IFN-gamma-regulated antimicrobial immunity","volume":"2019","author":"Krisnawati","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.imbio.2025.153134_bb0040","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01407-20","article-title":"GBP5 is an Interferon-Induced Inhibitor of respiratory Syncytial Virus","volume":"94","author":"Li","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2025.153134_bb0045","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/nm.4158","article-title":"Identification of a major epitope by anti-interferon-gamma autoantibodies in patients with mycobacterial disease","volume":"22","author":"Lin","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2025.153134_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.12791","article-title":"Mechanisms and functions of guanylate-binding proteins and related interferon-inducible GTPases: Roles in intracellular lysis of pathogens","volume":"19","author":"Ngo","year":"2017","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.imbio.2025.153134_bb0055","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1016\/j.jmb.2016.04.032","article-title":"Interferon-Inducible GTPases in Host Resistance, Inflammation and Disease","volume":"428","author":"Pilla-Moffett","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.imbio.2025.153134_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1051673","article-title":"Pathogen spectrum and immunotherapy in patients with anti-IFN-gamma autoantibodies: a multicenter retrospective study and systematic review","volume":"13","author":"Qiu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2025.153134_bb0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1203\/00006450-200107000-00005","article-title":"Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood","volume":"50","author":"Remus","year":"2001","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.imbio.2025.153134_bb0070","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1217141","article-title":"GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals","volume":"336","author":"Shenoy","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.imbio.2025.153134_bb0075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.coi.2021.05.007","article-title":"Anti-interferon-gamma autoantibody-associated immunodeficiency","volume":"72","author":"Shih","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imbio.2025.153134_bb0080","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20212126","article-title":"Pathogenic autoantibodies to IFN-gamma act through the impedance of receptor assembly and Fc-mediated response","volume":"219","author":"Shih","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2025.153134_bb0085","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/1535370218764086","article-title":"Characterization of anti-interferon-gamma antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms","volume":"243","author":"Wipasa","year":"2018","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.imbio.2025.153134_bb0090","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3389\/fimmu.2019.01905","article-title":"Neutralizing activity of anti-interferon-gamma autoantibodies in adult-onset immunodeficiency is associated with their binding domains","volume":"10","author":"Yasamut","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2025.153134_bb0095","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1038\/s41598-022-11774-9","article-title":"Determination of a distinguished interferon gamma epitope recognized by monoclonal antibody relating to autoantibody associated immunodeficiency","volume":"12","author":"Yasamut","year":"2022","journal-title":"Sci. Rep."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298525002682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298525002682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:09:33Z","timestamp":1781456973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298525002682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0171298525002682"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2025.153134","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of neutralizing anti-IFN-\u03b3 autoantibodies on GBP5 expression and monocyte dysfunction in adult-onset immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2025.153134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153134"}}